Advanced search

60 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024	05-17	GL
BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Collaborations GmbH on the domination and profit and loss transfer agreement pursuant to Section 293a AktG	05-03	PU
BioNTech : Annual Report 2023 with the Consolidated Financial Statements as of 31 December 2023, the Combined Management Report for BioNTech SE and the Group and the Report of the Supervisory Board for the 2023 financial year	05-03	PU
BioNTech : Compensation Report for the 2023 financial year	05-03	PU
Tonies : CVs of tonies SE Supervisory Board members according to Election Proposal	04-22	PU
Tonies : Voting Form	04-22	PU
Tonies : Remuneration Report 2023	04-22	PU
BioNTech : Invitation to the Annual General Meeting 2024 - Form 6-K	04-08	PU
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer	03-20	GL
BioNTech Announces Planned Retirement of Sean Marett	03-07	GL
BioNTech Announces Planned Retirement of Sean Marett	03-07	AQ
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	11-15	EQ
Tonies : Managers' transactions Managers' transaction notification	09/10/23	PU
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	09/10/23	EQ
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	28/09/23	EQ
Tonies : Managers' transactions Managers' transaction notification	07/09/23	PU
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	07/09/23	EQ
DD: Correction of a release from 28/08/2023, 18:00 CET/CEST - tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	29/08/23	EQ
Tonies : Managers' transactions Managers' transaction notification	28/08/23	PU
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	28/08/23	EQ
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer	14/08/23	GL
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer	14/08/23	AQ
Tonies : Managers' transactions Managers' transactions notice	21/07/23	PU
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	21/07/23	EQ
Tonies : Managers' transactions Managers' transaction notice	14/07/23	PU
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	14/07/23	EQ
DD: tonies SE: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	19/06/23	EQ
BioNTech : Invitation to the Annual General Meeting 2023 - Form 6-K	13/04/23	PU
BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Individualized mRNA Manufacturing GmbH on the domination and profit and loss transfer agreement pursuant to Sec. 293a of the German Stock Corporation Act	13/04/23	PU
BioNTech : Announces Second Quarter Financial Results and Corporate Update - Form 6-K	08/08/22	PU
BioNTech : Quarterly Report for the Three and Six Months Ended June 30, 2022 - Form 6-K	08/08/22	PU
BioNTech Announces Second Quarter Financial Results and Corporate Update	08/08/22	GL
BioNTech Announces Second Quarter Financial Results and Corporate Update	08/08/22	GL
Tonies SE : Notification and public disclosure of transactions by persons	22/07/22	EQ
Tonies SE : Notification and public disclosure of transactions by persons	09/06/22	EQ
BioNTech : Voting Results from BioNTech’s Annual General Meeting 2022 - Form 6-K	02/06/22	PU
Voting Results from BioNTech’s Annual General Meeting 2022	01/06/22	GL
Voting Results from BioNTech’s Annual General Meeting 2022	01/06/22	AQ
BioNTech : Invitation to the Annual General Meeting 2022 on June 1, 2022 - Form 6-K	21/04/22	PU
MIG Capital leads ?22.5 million Series B financing for Mimi Hearing Technologies	15/12/21	EQ
Berlin-based Mimi Hearing Technologies Closes $25 million Series B Funding to Become the World's Largest Platform for Hearing Wellbeing	15/12/21	PR
Tonies SE starts trading on the Frankfurt Stock Exchange through successful business combination with 468 SPAC	29/11/21	EQ
468 SPAC I SE: 468 SPAC I obtains 100% shareholder approval and 0.02% redemption rate, paving the way for its business combination with Boxine GmbH and listing as tonies SE	15/11/21	EQ
OQmented, Technology Leader in MEMS-Based AR/VR Display and 3D Sensing Solutions, Secures USD 9.3M of Funding	04/11/21	GL
AiCuris Anti infective Cures : AG Announces Dr. Stefan Oschmann, Former Merck CEO, to Chair the Supervisory Board	25/05/21	EQ
BioNTech : Broadens Management Board by Appointing Jens Holstein as CFO (Form 6-K)	18/05/21	PU
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers	24/03/21	PR
MIG Verwaltungs : Creative Balloons closes ?15 million growth financing and appoints Frank Gehres as CEO	24/02/21	EQ
AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG	01/02/21	EQ
BioNTech investor, amid worry over shortage, vows vaccines to be delivered for second shot	21/01/21	RE

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW